Research report
Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice

https://doi.org/10.1016/j.bbr.2005.02.023Get rights and content

Abstract

Parkinson's disease (PD) is one of the most common neurodegenerative disorders. Several toxin-induced animals models simulate the motor deficits occurring in PD. Among them, the unilateral 6-hydroxydopamine (6-OHDA) model is frequently used in rats and has the advantage of presenting side-biased motor impairments. However, the behavioral consequences of a unilateral 6-OHDA-lesion have, so far, not been described in detail in mice. The aim of this study was to characterize mice with unilateral 6-OHDA-lesions placed in the median forebrain bundle using several motor behavioral tests in order to identify the most suitable predictor of nigral cell loss. Mice underwent various drug-induced (amphetamine- and apomorphine-induced rotation) and spontaneous motor tests (cylinder, rotarod, elevated body swing, and stride length test). The amphetamine-induced rotation test, the cylinder and the rotarod test were most sensitive and reliable in detecting loss of tyrosine hydroxylase-immunoreactive cells in the substantia nigra.

This study demonstrates that substantial and stable unilateral 6-OHDA-induced lesions can be established in mice, and that these lesions can be functionally assessed using several different side-bias-based behavioral tests. This mouse model offers the opportunity to use transgenic mouse strains and study the interactions between genes of interest and toxins in relation to Parkinson's disease etiology in the future.

Introduction

Parkinson's Disease (PD) is the second most common neurodegenerative disorder. It is characterized by a marked loss of dopaminergic neurons of mainly the substantia nigra (SN) pars compacta leading to a reduction of dopamine (DA) in the target structure, the striatum [22]. The dopaminergic deficit results in motor disabilities, such as rigidity, akinesia, tremor and postural abnormalities as well as cognitive and vegetative disturbances [16].

The most frequently used toxins in rodent models of PD is either the neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP), or 6-hydroxydopamine (6-OHDA) [13]. Although MPTP is a valuable model of PD in mice and non-human primates, it is limited for several reasons: MPTP injection causes a bilateral Parkinson syndrome, thereby ruling out all behavioral tests based on a side bias. Cell loss is strain-, age- and gender-dependent in mice [47]. More importantly, a spontaneous recovery of Parkinsonian symptoms has been described in both, monkeys [15], [50] and mice [45], [46] after MPTP administration, which causes concern to use this model for an assessment of long-term therapeutic effects of a compound or neural grafts.

6-OHDA is a neurotoxin that selectively destroys catecholaminergic neurons and it is typically injected unilaterally, since bilateral injections cause high mortality. The advantage using this model is that it lends itself to more easy assessment of motor impairments by utilizing tests that examine for a side bias, e.g. drug-induced rotation tests [53] and spontaneous motor tests. Furthermore, intracerebral injection of 6-OHDA into the rat nigrostriatal pathway has been shown to permanently degenerate virtually all dopaminergic neurons in the SN pars compacta [25], [26] leading to stable motor deficits over time. The toxin can be injected intrastriatally, into the median forebrain bundle (MFB) or directly into the SN. Only very few studies concerning mice with 6-OHDA-lesions have been published before. In these studies, 6-OHDA was injected mainly either intrastriatally [6], [9], [12], [31] or intraventricularly, and the mice were subjected to relatively little behavioral assessment [3], [4], [7]. More recently, new models of PD have been established that rely on genetic manipulations in mice. A number of laboratories have now generated different mouse strains that carry mutations in proteins or receptors that are critical for the function of the dopaminergic system. These include α-synuclein-overexpressing mice [32], α-synuclein-knockout mice [1], Parkin-knockout mice [20], [24], several knockout mice for dopamine receptors [5], [33], [49] and tyrosine hydroxylase (TH, the rate-limiting enzyme of dopamine synthesis), and a mouse with a UCH-L1 gene mutation [41]. With an increasing availability of genetically modified mice that model PD, we believe that characterizing toxin-induced lesions in mice is highly warranted. PD models are also used to demonstrate therapeutic effects of neural grafts as a promising approach to brain repair [14]. Thereby, in the future, new models could be created that combine genetic and toxin methodologies to investigate the pathogenesis of PD or the influence of a certain genetic background on graft properties, such as cell survival and fiber outgrowth.

In the present study, we injected the 6-OHDA unilaterally into the MFB to achieve retrograde dopaminergic cell loss in the SN.

We provide an extensive behavioral characterization of motor deficits by applying multiple behavioral tests, such as amphetamine- and apomorphine-induced rotation, the rotarod test, the cylinder test, the elevated body swing test (EBST) and the stride length test. By comparing behavioral outcome with the degree of nigral cell loss in individual mice, we have determined which of these tests best predict SN cell loss, and which tests should be used for selecting for adequately lesioned mice.

Section snippets

Animals

Hundred and ten adult female CBA mice (20 g, B&K, Stockholm, Sweden) were lesioned and all animals were tested for amphetamine-induced rotation at 3 and 6 weeks post-lesion. Out of these 110 mice, 53 mice were selected for the present study. This selection was based on their amphetamine rotation scores at 6 weeks after the 6-OHDA injections. We aimed to include mice with a large range of different amphetamine rotation scores for the study. The remaining mice were used in another study. Seven

Results

Fifty-three lesioned mice were included in the behavioral analysis based on their ipsilateral amphetamine-induced rotation scores ranging from −6.3 to 12.0 rotations/minute. Out of these mice, four were excluded due to a poor needle placement according to the analysis of the cresyl violet stains. Therefore, the statistical analysis is based on a total of 49 lesioned mice and seven non-lesioned control mice.

Discussion

We show that it is possible to achieve a permanent loss of midbrain dopaminergic neurons after injecting 6-OHDA unilaterally into the MFB. This study identified several behavioral motor tests sensitive to detecting this unilateral nigral cell loss in mice.

As mentioned above, we selected 53 mice out of 110 mice subjected to the lesion. The selected mice showed a wide variability regarding loss of dopaminergic SN neurons probably due to the small size of the MFB that makes it difficult to target

Acknowledgments

We would like to thank Birgit Haraldsson and Britt Lindberg for excellent technical assistance. The study was supported by the NIH Grant no 1 R21 NS043717-01A1, the Swedish Research Council and the Konung Gustaf V:s and Drottning Victorias Stiftelse.

References (57)

  • A. Abeliovich et al.

    Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

    Neuron

    (2000)
  • D.N. Abrous et al.

    Behavioural recovery after unilateral lesion of the dopaminergic mesotelencephalic pathway: effect of repeated testing

    Neuroscience

    (1998)
  • T. Archer et al.

    Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment

    Neurotoxicol Res

    (2003)
  • M. Asanuma et al.

    Protective effects of pergolide on dopamine levels in the 6-hydroxydopamine-lesioned mouse brain

    Arch Int Pharmacodyn Ther

    (1995)
  • J.H. Baik et al.

    Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors

    Nature

    (1995)
  • J.C. Bensadoun et al.

    Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF

    Exp Neurol

    (2000)
  • J.C. Bensadoun et al.

    Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice

    Eur J Neurosci

    (1998)
  • C.V. Borlongan et al.

    Elevated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism

    J Neurosci

    (1995)
  • P. Brundin et al.

    The rotating 6-hydroxydopamine-lesioned mouse as a model for assessing functional effects of neuronal grafting

    Brain Res

    (1986)
  • J.J. Canales et al.

    A measure of striatal function predicts motor stereotypy

    Nature Neurosci

    (2000)
  • I. Creese et al.

    Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity

    Science

    (1977)
  • L.A. Cunningham et al.

    Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease

    Exp Neurol

    (2002)
  • W. Dauer et al.

    Parkinson's disease: mechanisms and models

    Neuron

    (2003)
  • S.B. Dunnett et al.

    Prospects for new restorative and neuroprotective treatments in Parkinson's disease

    Nature

    (1999)
  • E. Eidelberg et al.

    Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinsonism in monkeys

    Neuroscience

    (1986)
  • S. Fahn

    Description of Parkinson's disease as a clinical syndrome

    Ann NY Acad Sci

    (2003)
  • P.O. Fernagut et al.

    A simple method to measure stride length as an index of nigrostriatal dysfunction in mice

    J Neurosci Methods

    (2002)
  • K.B.J. Franklin et al.

    The mouse brain in stereotaxic coordinates

    (1997)
  • G.M. Friehs et al.

    Lesioning of the striatum reverses motor asymmetry in the 6-hydroxydopamine rodent model of Parkinsonism

    J Neural Transplant Plast

    (1991)
  • M.S. Goldberg et al.

    Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons

    J Biol Chem

    (2003)
  • J.M. Henderson et al.

    Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat

    Behav Brain Res

    (2003)
  • O. Hornykiewicz

    The tropical localization and content of noradrenalin and dopamine (3-hydroxytyramine) in the substantia nigra of normal persons and patients with Parkinson's disease

    Wien Klin Wochenschr

    (1963)
  • J.L. Hudson et al.

    Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats

    Brain Res

    (1993)
  • J.M. Itier et al.

    Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse

    Hum Mol Genet

    (2003)
  • F. Javoy et al.

    Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system

    Brain Res

    (1976)
  • B.S. Jeon et al.

    6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death

    Neurodegeneration

    (1995)
  • D. Kirik et al.

    Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat

    Exp Neurol

    (1998)
  • D. Kirik et al.

    Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor

    Eur J Neurosci

    (2000)
  • Cited by (0)

    View full text